TTENK/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

TTENK/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Groups
  • Trending
  • News

More

  • Pricing
  • Community
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice.TENK is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities TENK rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. TENK/calls is an independent service and is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

TTENK/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Pulling SEC filings + quote and writing the call…

TTENK/calls
The BriefMarketsAll StocksNewsScreenerCommunity
← New search
Home›Stocks›GSHD

GSHD

Goosehead Insurance, Inc.

Next earnings Jul 21, 2026 (after close) · consensus $0.52 EPS, $106M rev

Last earnings +2.0% on 2026-04-22

Hold
$52.69
▲ +9.82%
$52.69▼ -48.54%
over 1Y
L $34.37H $105.51
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+9.8%
1W+19.8%
1M+46.0%
3M+24.2%
YTD-24.9%
1Y-48.5%
OverviewFinancialsValuationQualityTimelineFilings
Rating
Hold
Quality
C-
Valuation
Overvalued
Filings
Flagged
Hold
Conviction
Horizon
Long (>12mo)
12-mo target
$•••
Street · 19 analysts
Buy

High-quality, cash-gushing P&C broker compounding mid-teens — but a debt-funded, negative-equity balance sheet and 46x earnings leave no margin for error.

Revenue $365M · FY2025

The read

Middling fundamentals and a rich price (~72% above fair value) leave little margin of safety — a wait-and-see.

Goosehead remains a genuinely good operating business. Revenue has climbed every year from $151M (FY2021) to $365M (FY2025), a clean +16.2% in the latest year, and operating income grew faster (+21.8% to $74.4M, a 20.4% operating margin) — the franchise/royalty model is scaling profitably. Most importantly, operating cash flow of $91.8M (+28.3%) badly outruns the $27.8M of GAAP net income, so the headline 46x P/E overstates how expensive the cash economics are: FCF after the $5.67M of capex is ~$86M, a ~7% yield on the $1.20B cap. The -8.5% dip in net income and -10.3% EPS is a financing artifact (interest on newly raised debt and the holding-company structure), not operational decay.

The balance sheet, however, demands respect. Stockholders' equity is now -$95.5M and retained earnings -$133M, the product of deliberate financial engineering rather than losses: the company paid $146M in dividends and bought back $81.7M of stock in FY2025 — $228M of capital returns against $27.8M of earnings — funded by long-term debt that ballooned 252% to $289M. That return pace exceeds even the strong ~$86M of free cash flow and is not repeatable without continued borrowing. The 10-K is explicit that this is an Up-C holding company with 'no material assets other than our ownership of LLC Units,' whose dividend capacity is constrained by the Credit Agreement and a $171.9M tax-receivable-agreement obligation to Pre-IPO members. The negative equity is structural, not distress, but it removes any cushion.

AI-generated analysis, produced by our proprietary engine from SEC filing data.

Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jun 30, 2026, 5:26 AM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.

Financials · annual, by fiscal year

Line itemFY21FY22FY23FY24FY25
Revenue$151M$209M$261M$315M$365M
Gross profit—————
Operating income$8.67M$10.1M$33.0M$61.1M$74.4M
Net income$5.40M$565K$14.1M$30.4M$27.8M
Diluted EPS$0.26$0.03$0.55$1.16$1.04
Net margin3.6%0.3%5.4%9.7%7.6%

Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.

Key statistics

Valuation

Enterprise value$2.13B
EV / EBITDA24.9
EV / Sales5.8
EV / FCF24.8
P / FCF21.8
PEG (trailing)—
Earnings yield1.5%
FCF yield4.6%

Quality & risk

ROIC (est.)—
Free cash flow$86.1M
Total debt$292M
Net cash-$258M
Altman Z-Score3.07 safe
Piotroski F-Score4/8

Capital returns

Buyback yield4.4%
Dividend yield (est.)7.8%
Shareholder yield12.1%
Shares Δ YoY+1.3%

Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.

Disclosure timeline

SEC · 8-Ks + reports
Recent disclosure tone has skewed negative — read the flagged items.
  1. 8-K Shareholder vote2026-05-04

    Annual meeting voting results: directors elected, routine proposals ratified

  2. 10-Q Quarterly report2026-04-23

    Q1'26 quarterly report; growth continues atop FY25 revenue of $365M

  3. 8-K Officer / director change2026-04-22

    Q1'26 results released alongside an executive/board change and other update

  4. 8-K/A Amended 8-K2026-04-08

    Amended prior 8-K to update/correct previously furnished disclosure

  5. 8-K Officer / director change2026-03-31

    Leadership change (officer/director) plus an other-events disclosure

  6. DEF 14A Proxy statement2026-03-25

    2026 proxy: board slate, exec pay and auditor up for shareholder vote

  7. 10-K Annual report2026-02-19

    FY25 rev +16% but NI -9%, EPS -10%; debt-funded $146M dividend turned equity negative

  8. 8-K Officer / director change2026-02-17

    FY25 results: revenue +16% but EPS -10%; also an exec change and Reg FD update

  9. 10-Q Quarterly report2025-10-23

    Q3'25 quarterly report; revenue growth on track to FY25

Recent filings

all on EDGAR ↗
SCHEDULE 13G/AFiling2026-06-04open ↗4Period ending 2026-05-292026-06-01open ↗4Period ending 2026-05-282026-05-29open ↗4Period ending 2026-05-272026-05-27open ↗4Period ending 2026-05-262026-05-26open ↗4Period ending 2026-05-222026-05-22open ↗4Period ending 2026-05-212026-05-21open ↗4Period ending 2026-05-182026-05-18open ↗4Period ending 2026-05-152026-05-15open ↗4Period ending 2026-05-142026-05-15open ↗SCHEDULE 13G/AFiling2026-05-15open ↗SCHEDULE 13G/AFiling2026-05-14open ↗

Quality score

C-
ValueGrowthProfitHealthMom.
ValueD
GrowthC
ProfitabilityB
Financial healthF
MomentumD
  • ✓Revenue growing year-over-year
  • ✓Profitable (positive net income)
  • ✗Net margin above 10%
  • ✓Liabilities below 2× equity
  • ✗P/E below 25

Fair value est.

$14.79

Overvalued -72% vs price

cheapfair valueexpensive

Modified Graham: EPS $1.04 × (8.5 + 1.5 × 3.8% growth) × 1.00 quality = 14.2× multiple. An estimate, not a price target.

34.3752-week103.43
Revenue
$365M
+16.2% YoY
Net margin
7.6%
ROE
—
P/E
50.7

SEC fundamentals · FY 2025

'21'22'23'24'25

■ revenue · ■ net income, by fiscal year

Revenue$365M+16.2%
Net income$27.8M-8.5%
Operating income$74.4M+21.8%
Diluted EPS$1.04-10.3%
Cash & equivalents$34.4M-36.6%
Total assets$415M+4.3%
Total liabilities$578M+61.1%
Stockholders' equity-$95.5M-317.6%
Op.: 20.4%L/E: -6.05x

Frequently asked

Is Goosehead Insurance, Inc. (GSHD) a buy?
GSHD currently carries a Hold rating with 4/5 conviction, derived from its latest SEC filings. High-quality, cash-gushing P&C broker compounding mid-teens — but a debt-funded, negative-equity balance sheet and 46x earnings leave no margin for error.
What is GSHD's fair value?
A Modified-Graham model based on GSHD's SEC fundamentals estimates a fair value of about $14.79. It is an estimate from reported earnings, not a price target.
Is GSHD overvalued or undervalued?
Against a Modified-Graham fair-value estimate, GSHD currently appears overvalued relative to its SEC-grounded earnings power.
What is Goosehead Insurance, Inc.'s quality score?
GSHD scores 53.016225866748464/100 (grade C-) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.

Sources: SEC EDGAR (CIK 0001726978, latest 10-Q filed 2026-04-23) · EODHD · Proprietary analysis · as of 6/30/2026, 9:26:22 AM.

Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.

Insider activity

Form 4 · SEC

Last 90 days: 4 open-market buys · 8 sales

2026-05-29
Langston Patrick Ryan
10% owner
Buy2.80K @ $35.56$99.6K
2026-05-28
Martin John Arthur
Chief Financial Officer
Buy5.00K @ $34.73$174K
2026-05-27
Mark & Robyn Jones Descendants Trust 2014
Executive Chairman
Disposed (C)9.59K
2026-05-27
Mark & Robyn Jones Descendants Trust 2014
Executive Chairman
Acquired (C)9.59K
2026-05-27
Mark & Robyn Jones Descendants Trust 2014
Executive Chairman
Sell6.47K @ $40.51$262K
2026-05-27
Mark & Robyn Jones Descendants Trust 2014
Executive Chairman
Sell3.12K @ $41.28$129K
2026-05-26
Mark & Robyn Jones Descendants Trust 2014
Executive Chairman
Disposed (C)45.6K
2026-05-26
Mark & Robyn Jones Descendants Trust 2014
Executive Chairman
Acquired (C)45.6K
2026-05-26
Mark & Robyn Jones Descendants Trust 2014
Executive Chairman
Sell45.6K @ $40.07$1.83M
2026-05-22
Mark & Robyn Jones Descendants Trust 2014
Executive Chairman
Disposed (C)82.7K
2026-05-22
Mark & Robyn Jones Descendants Trust 2014
Executive Chairman
Acquired (C)82.7K
2026-05-22
Mark & Robyn Jones Descendants Trust 2014
Executive Chairman
Sell79.3K @ $41.74$3.31M

Dividends

Irregular
Yield (TTM)
—
Annual / share
—
Last ex-date
2025-01-21
Last amount
$5.91
ex 2025-01-21paid 2025-01-31$5.91
ex 2021-08-06paid 2021-08-23$1.63
ex 2020-08-07paid 2020-08-24$1.15
ex 2019-03-15paid 2019-04-01$0.41

Source: EODHD. Yield = trailing-12-month dividends ÷ price.

Earnings history

beat/miss · move
2026-04-22Beat +79.4% est▲ +2.04%8-K ↗
2026-02-17Beat +9.1% est▲ +3.98%8-K ↗
2025-10-22Miss -1.6% est▲ +0.59%8-K ↗
2025-07-23Miss -4.0% est▲ +2.62%8-K ↗
2025-04-23—▲ +2.60%8-K ↗
2025-02-24—▼ -0.97%8-K ↗

Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.

Recent news

market news →
Goosehead (GSHD) Soars 6.6%: Is Further Upside Left in the Stock?Bullish
finance.yahoo.com· 2026-06-29
Insurers in gainers; Goldman Sachs, Morgan Stanley among losers: week's financials wrapBearish
seekingalpha.com· 2026-06-27
Goosehead Insurance (GSHD) is One of the Best Small-Cap Financial Stocks, Here is WhyBullish
finance.yahoo.com· 2026-06-23
5 Best Small-Cap Financial Stocks to Buy NowBullish
finance.yahoo.com· 2026-06-22
Goosehead Insurance, Inc. Names Eben Hewitt as Chief Technology OfficerBullish
finance.yahoo.com· 2026-06-15
3 Stocks That May Be Priced Below Their Estimated Value In June 2026Bullish
finance.yahoo.com· 2026-06-08

Vs tracked universe

compare →

1195 tracked peers · median

TENK Score53 vs 67
Revenue growth16.2% vs 7.5%
Net margin7.6% vs 10.0%
Return on equity— vs 12.0%
P/E50.7 vs 26.2

News sentiment

EODHD · 10d
Bearish
-0.11
vs typical · 12 articles
↓ cooling

Recent news tone vs the market's typical (which skews positive). A soft signal, not a recommendation.